Assessment of the Proportion of Recent HIV-1 Infections in Newly-Diagnosed Cases in Ghana
Accurate monitoring of epidemics is a key strategy for controlling human immunodeficiency virus type-1 (HIV-1) infection. To delineate the characteristics of newly diagnosed cases of HIV-1 infection, we assessed the proportion of recent HIV-1 infections using a recent infection-testing algorithm (RI...
Saved in:
Published in | Japanese Journal of Infectious Diseases Vol. 75; no. 4; pp. 395 - 397 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Japan
National Institute of Infectious Diseases, Japanese Journal of Infectious Diseases Editorial Committee
31.07.2022
Japan Science and Technology Agency |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Accurate monitoring of epidemics is a key strategy for controlling human immunodeficiency virus type-1 (HIV-1) infection. To delineate the characteristics of newly diagnosed cases of HIV-1 infection, we assessed the proportion of recent HIV-1 infections using a recent infection-testing algorithm (RITA). In 2015, 248 cases were newly diagnosed with HIV infection at the Regional Hospital Koforidua, Ghana. Of these, 234 cases (94.4%) were infected with HIV-1 only, four (1.6%) were infected with HIV-2 only, and 10 (4.0%) were co-infected with HIV-1 and HIV-2. All HIV-1 single-seropositive samples were used in the HIV-1 LAg avidity assay for RITA. Our analysis revealed that 18 cases (7.7%) were recently infected, indicating that early diagnosis was not achieved in Ghana. This is the first report to assess the proportion of recent infections in Ghana using a biomarker approach. The accumulation of these data will contribute to the accurate estimation of HIV-1 incidence and prevalence in Ghana. |
---|---|
AbstractList | Accurate monitoring of epidemics is a key strategy for controlling human immunodeficiency virus type-1 (HIV-1) infection. To delineate the characteristics of newly diagnosed cases of HIV-1 infection, we assessed the proportion of recent HIV-1 infections using a recent infection-testing algorithm (RITA). In 2015, 248 cases were newly diagnosed with HIV infection at the Regional Hospital Koforidua, Ghana. Of these, 234 cases (94.4%) were infected with HIV-1 only, four (1.6%) were infected with HIV-2 only, and 10 (4.0%) were co-infected with HIV-1 and HIV-2. All HIV-1 single-seropositive samples were used in the HIV-1 LAg avidity assay for RITA. Our analysis revealed that 18 cases (7.7%) were recently infected, indicating that early diagnosis was not achieved in Ghana. This is the first report to assess the proportion of recent infections in Ghana using a biomarker approach. The accumulation of these data will contribute to the accurate estimation of HIV-1 incidence and prevalence in Ghana. Accurate monitoring of epidemics is a key strategy for controlling human immunodeficiency virus type-1 (HIV-1) infection. To delineate the characteristics of newly diagnosed cases of HIV-1 infection, we assessed the proportion of recent HIV-1 infections using a recent infection-testing algorithm (RITA). In 2015, 248 cases were newly diagnosed with HIV infection at the Regional Hospital Koforidua, Ghana. Of these, 234 cases (94.4%) were infected with HIV-1 only, four (1.6%) were infected with HIV-2 only, and 10 (4.0%) were co-infected with HIV-1 and HIV-2. All HIV-1 single-seropositive samples were used in the HIV-1 LAg avidity assay for RITA. Our analysis revealed that 18 cases (7.7%) were recently infected, indicating that early diagnosis was not achieved in Ghana. This is the first report to assess the proportion of recent infections in Ghana using a biomarker approach. The accumulation of these data will contribute to the accurate estimation of HIV-1 incidence and prevalence in Ghana.Accurate monitoring of epidemics is a key strategy for controlling human immunodeficiency virus type-1 (HIV-1) infection. To delineate the characteristics of newly diagnosed cases of HIV-1 infection, we assessed the proportion of recent HIV-1 infections using a recent infection-testing algorithm (RITA). In 2015, 248 cases were newly diagnosed with HIV infection at the Regional Hospital Koforidua, Ghana. Of these, 234 cases (94.4%) were infected with HIV-1 only, four (1.6%) were infected with HIV-2 only, and 10 (4.0%) were co-infected with HIV-1 and HIV-2. All HIV-1 single-seropositive samples were used in the HIV-1 LAg avidity assay for RITA. Our analysis revealed that 18 cases (7.7%) were recently infected, indicating that early diagnosis was not achieved in Ghana. This is the first report to assess the proportion of recent infections in Ghana using a biomarker approach. The accumulation of these data will contribute to the accurate estimation of HIV-1 incidence and prevalence in Ghana. Accurate monitoring of epidemics is a key strategy for the control of human immunodeficiency virus type-1 (HIV-1) infection. To delineate the characteristic of newly-diagnosed cases of HIV-1 infection, we assessed the proportion of recent HIV-1 infections using a recent infection testing algorithm (RITA). In 2015, 248 cases were newly diagnosed with HIV infection in Reginal Hospital Koforidua, Ghana. Of these, 234 cases (94.4%) were infected with HIV-1 only, four (1.6%) were infected with HIV-2 only, and 10 (4.0%) were co-infected with HIV-1 and HIV-2. All the HIV-1 single seropositive samples were applied to HIV-1 LAg avidity assay for RITA. Our analysis revealed that 18 cases (7.7%) were determined as recent infections, indicating that early diagnosis has not been achieved in Ghana. This is the first report assessing the proportion of recent infections in Ghana using a biomarker approach. Accumulation of these data would contribute to accurate estimation of HIV-1 incidence and prevalence in Ghana. |
ArticleNumber | JJID.2021.573 |
Author | Ishikawa, Koichi Ampofo, William Kwabena Abana, Christopher Zab-Yen Bonney, Evelyn Yayra Ofori, Sampson Badu Okazaki, Midori Kawana-Tachikawa, Ai Matano, Tetsuro Matsuoka, Saori Adusei-Poku, Mildred Asumamaa Duker, Ewurabena Oduma Parbie, Prince Kofi |
Author_xml | – sequence: 1 fullname: Matsuoka, Saori organization: AIDS Research Center, National Institute of Infectious Diseases, Japan – sequence: 2 fullname: Adusei-Poku, Mildred Asumamaa organization: AIDS Research Center, National Institute of Infectious Diseases, Japan – sequence: 3 fullname: Abana, Christopher Zab-Yen organization: Noguchi Memorial Institute for Medical Research, University of Ghana, Ghana – sequence: 4 fullname: Duker, Ewurabena Oduma organization: Noguchi Memorial Institute for Medical Research, University of Ghana, Ghana – sequence: 5 fullname: Bonney, Evelyn Yayra organization: Noguchi Memorial Institute for Medical Research, University of Ghana, Ghana – sequence: 6 fullname: Ofori, Sampson Badu organization: Regional Hospital Koforidua, Ghana Health Service, Ghana – sequence: 7 fullname: Parbie, Prince Kofi organization: AIDS Research Center, National Institute of Infectious Diseases, Japan – sequence: 8 fullname: Okazaki, Midori organization: AIDS Research Center, National Institute of Infectious Diseases, Japan – sequence: 9 fullname: Kawana-Tachikawa, Ai organization: AIDS Research Center, National Institute of Infectious Diseases, Japan – sequence: 10 fullname: Ishikawa, Koichi organization: AIDS Research Center, National Institute of Infectious Diseases, Japan – sequence: 11 fullname: Ampofo, William Kwabena organization: Noguchi Memorial Institute for Medical Research, University of Ghana, Ghana – sequence: 12 fullname: Matano, Tetsuro organization: AIDS Research Center, National Institute of Infectious Diseases, Japan |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34980705$$D View this record in MEDLINE/PubMed |
BookMark | eNpdkU9v1DAQxS3Uiv6BT4CEInHpJVvbYyf2sdrSNlUFCAESJ8tNJt0sWXuxs6r229dml5XgYlvzfm80nndGjpx3SMg7Rme1UnC59b_Qze7vm-sZp5zNZA2vyClTSpRcQXWU3iBEWQEVJ-QsxiWlXEpGX5MTEFrRmspT8vMqRoxxhW4qfF9MCyy-BL_2YRq8y5Wv2GbtrvlRsqJxPbZZicXgik_4PG7L68E-OR-xK-Y2tcrC7cI6-4Yc93aM-HZ_n5PvNx-_ze_Kh8-3zfzqoWwll1BaXbWdEnXHlbAAWuiuA9QAwACsQGQ9k2C1UAJrq3vK00A9SrT4yJlVcE4udn3Xwf_eYJzMaogtjqN16DfR8IpVVfq6zuiH_9Cl3wSXpkuUrpkUwHii3u-pzeMKO7MOw8qGrfm7tATADmiDjzFgf0AYNTka8ycak6MxORqTokmuZudaxsk-4cFj06rbEfeeWhqRj3-8B6Zd2GDQwQsi3psH |
Cites_doi | 10.7883/yoken.JJID.2019.201 10.1001/jama.300.5.520 10.1371/journal.pone.0033328 10.1097/EDE.0000000000000324 10.1186/1758-2652-12-19 10.1016/j.pmedr.2019.100994 10.1093/oso/9780195076417.003.0008 |
ContentType | Journal Article |
Copyright | 2022 Authors Copyright Japan Science and Technology Agency 2022 |
Copyright_xml | – notice: 2022 Authors – notice: Copyright Japan Science and Technology Agency 2022 |
DBID | AAYXX CITATION NPM 7QL 7T5 7T7 7TK 7U9 8FD C1K FR3 H94 M7N P64 7X8 |
DOI | 10.7883/yoken.JJID.2021.573 |
DatabaseName | CrossRef PubMed Bacteriology Abstracts (Microbiology B) Immunology Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) Neurosciences Abstracts Virology and AIDS Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database AIDS and Cancer Research Abstracts Algology Mycology and Protozoology Abstracts (Microbiology C) Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitle | CrossRef PubMed Virology and AIDS Abstracts Technology Research Database Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) AIDS and Cancer Research Abstracts Immunology Abstracts Engineering Research Database Industrial and Applied Microbiology Abstracts (Microbiology A) Neurosciences Abstracts Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | Virology and AIDS Abstracts MEDLINE - Academic PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1884-2836 |
EndPage | 397 |
ExternalDocumentID | 34980705 10_7883_yoken_JJID_2021_573 article_yoken_75_4_75_JJID_2021_573_article_char_en |
Genre | Journal Article |
GeographicLocations | Ghana |
GeographicLocations_xml | – name: Ghana |
GroupedDBID | --- .55 29J 2WC 53G 5GY ACPRK ADBBV AENEX AFRAH ALMA_UNASSIGNED_HOLDINGS BAWUL DIK DU5 E3Z EBS EJD F5P FRP GX1 JSF JSH KQ8 OK1 RJT RNS RZJ TR2 W2D X7M XSB AAYXX CITATION OVT NPM 7QL 7T5 7T7 7TK 7U9 8FD C1K FR3 H94 M7N P64 7X8 |
ID | FETCH-LOGICAL-c5253-a96cd847d284a33949dd3e9333133a4ee1f153a9484e7a9f02ecefe5eaeb21a83 |
ISSN | 1344-6304 1884-2836 |
IngestDate | Thu Jul 10 23:54:39 EDT 2025 Mon Jun 30 12:02:42 EDT 2025 Mon Jul 21 05:56:02 EDT 2025 Tue Jul 01 03:55:17 EDT 2025 Thu Aug 17 20:30:57 EDT 2023 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | HIV-1 Recent infection Ghana Incidence |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c5253-a96cd847d284a33949dd3e9333133a4ee1f153a9484e7a9f02ecefe5eaeb21a83 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | https://www.jstage.jst.go.jp/article/yoken/75/4/75_JJID.2021.573/_article/-char/en |
PMID | 34980705 |
PQID | 2697154312 |
PQPubID | 2048383 |
PageCount | 3 |
ParticipantIDs | proquest_miscellaneous_2616600298 proquest_journals_2697154312 pubmed_primary_34980705 crossref_primary_10_7883_yoken_JJID_2021_573 jstage_primary_article_yoken_75_4_75_JJID_2021_573_article_char_en |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2022/07/31 |
PublicationDateYYYYMMDD | 2022-07-31 |
PublicationDate_xml | – month: 07 year: 2022 text: 2022/07/31 day: 31 |
PublicationDecade | 2020 |
PublicationPlace | Japan |
PublicationPlace_xml | – name: Japan – name: Tokyo |
PublicationTitle | Japanese Journal of Infectious Diseases |
PublicationTitleAlternate | Jpn J Infect Dis |
PublicationYear | 2022 |
Publisher | National Institute of Infectious Diseases, Japanese Journal of Infectious Diseases Editorial Committee Japan Science and Technology Agency |
Publisher_xml | – name: National Institute of Infectious Diseases, Japanese Journal of Infectious Diseases Editorial Committee – name: Japan Science and Technology Agency |
References | 14. Matsuoka S, Nagashima M, Sadamasu K, et al. Estimating HIV-1 incidence in Japan from the proportion of recent infections. Prev Med Rep. 2019;16:100994. 9. Sedia Biosiences Corrporation. Sedia HIV-1 LAg Avidity EIA. 2018. 13. Ghana AIDS Committee. 2019 HIV sentimental survey report. Available at <https://www.ghanaids.gov.gh/>. Acceded February 18, 2021. 3. WHO. When and how to use assays for recent infection to estimate HIV incidence at a population level. Available at <https://apps.who.int/iris/handle/10665/44612>. Accessed June 29, 2022. 6. Public Health England. Progress towards ending the HIV epidemic in the United Kingdom, 2018 report. Available at <https://www.gov.uk/government/publications/hiv-in-the-united-kingdom>. Acceded February 18, 2021. 8. Wand L, Wilson D, Yan P, et al. Characterizing trends in HIV infection among men who have sex with men in Australia by birth cohorts: results from a modified back-projection method. J Int AIDS Soc. 2009:12;19. 7. The Kirby Institute. HIV, viral hepatitis and sexually transmissible infections in Australia, annual surveillance report 2018. Available at <https://kirby.unsw.edu.au/report/hiv-viral-hepatitis-and-sexually-transmissible-infections-australia-annual-surveillance>. Acceded February 18, 2021. 12. Joint United Nations Programme on HIV/AIDS (UANIDS). Fact sheet Ghana. UNAIDS. 2019. Available at <https://www.unaids.org/en/regionscountries/countries/ghana>. Acceded February 18, 2021. 15. Adusei-Poku MA, Matsuoka S, Bonney EY, et al. Human leukocyte antigen-associated HIV-1 CRF02_AG gag and vif paccordingolymorphisms in Ghana. Jpn J Infect Dis. 2019;72:374-380. 5. van Sighem A, Nakagawa F, De Angelis D, et al. Estimating HIV incidence, time to diagnosis, and the undiagnosed HIV epidemic using routine surveillance data. Epidemiology. 2015;25:653-660. 4. WHO. WHO working group on HIV incidence measurement and data use: meeting report. 2018. Available at <https://apps.who.int/iris/handle/10665/272940>. Acceded February 18, 2021. 10. Hall HI, Song R, Rhodes P, et al. Estimation of HIV incidence in the United States. JAMA. 2008;300:520-529. 1. Brookmeyer R, Gail MH. Generalized back-calculation: extension to account for nonstationary incubation distributions. In: AIDS Epidemiology: A Quantitative Approach. New York: Oxford University Press; 1994. p.219. 11. Duong YT, Qiu M, De AK, et al. Detection of recent HIV-1 infection using a new limiting-antigen avidity assay: potential for HIV-1 incidence estimates and avidity maturation studies. PLoS One. 2012;7:e33328. 2. World Health Organization (WHO): WHO working group on HIV incidence assays. Estimating HIV incidence using HIV case surveillance. Available at <https://www.who.int/publications/i/item/WHO-HIV-2017.03>. Accessed June 29, 2022. 11 12 13 14 15 1 2 3 4 5 6 7 8 9 10 |
References_xml | – reference: 11. Duong YT, Qiu M, De AK, et al. Detection of recent HIV-1 infection using a new limiting-antigen avidity assay: potential for HIV-1 incidence estimates and avidity maturation studies. PLoS One. 2012;7:e33328. – reference: 12. Joint United Nations Programme on HIV/AIDS (UANIDS). Fact sheet Ghana. UNAIDS. 2019. Available at <https://www.unaids.org/en/regionscountries/countries/ghana>. Acceded February 18, 2021. – reference: 14. Matsuoka S, Nagashima M, Sadamasu K, et al. Estimating HIV-1 incidence in Japan from the proportion of recent infections. Prev Med Rep. 2019;16:100994. – reference: 4. WHO. WHO working group on HIV incidence measurement and data use: meeting report. 2018. Available at <https://apps.who.int/iris/handle/10665/272940>. Acceded February 18, 2021. – reference: 10. Hall HI, Song R, Rhodes P, et al. Estimation of HIV incidence in the United States. JAMA. 2008;300:520-529. – reference: 5. van Sighem A, Nakagawa F, De Angelis D, et al. Estimating HIV incidence, time to diagnosis, and the undiagnosed HIV epidemic using routine surveillance data. Epidemiology. 2015;25:653-660. – reference: 1. Brookmeyer R, Gail MH. Generalized back-calculation: extension to account for nonstationary incubation distributions. In: AIDS Epidemiology: A Quantitative Approach. New York: Oxford University Press; 1994. p.219. – reference: 8. Wand L, Wilson D, Yan P, et al. Characterizing trends in HIV infection among men who have sex with men in Australia by birth cohorts: results from a modified back-projection method. J Int AIDS Soc. 2009:12;19. – reference: 7. The Kirby Institute. HIV, viral hepatitis and sexually transmissible infections in Australia, annual surveillance report 2018. Available at <https://kirby.unsw.edu.au/report/hiv-viral-hepatitis-and-sexually-transmissible-infections-australia-annual-surveillance>. Acceded February 18, 2021. – reference: 9. Sedia Biosiences Corrporation. Sedia HIV-1 LAg Avidity EIA. 2018. – reference: 13. Ghana AIDS Committee. 2019 HIV sentimental survey report. Available at <https://www.ghanaids.gov.gh/>. Acceded February 18, 2021. – reference: 3. WHO. When and how to use assays for recent infection to estimate HIV incidence at a population level. Available at <https://apps.who.int/iris/handle/10665/44612>. Accessed June 29, 2022. – reference: 15. Adusei-Poku MA, Matsuoka S, Bonney EY, et al. Human leukocyte antigen-associated HIV-1 CRF02_AG gag and vif paccordingolymorphisms in Ghana. Jpn J Infect Dis. 2019;72:374-380. – reference: 2. World Health Organization (WHO): WHO working group on HIV incidence assays. Estimating HIV incidence using HIV case surveillance. Available at <https://www.who.int/publications/i/item/WHO-HIV-2017.03>. Accessed June 29, 2022. – reference: 6. Public Health England. Progress towards ending the HIV epidemic in the United Kingdom, 2018 report. Available at <https://www.gov.uk/government/publications/hiv-in-the-united-kingdom>. Acceded February 18, 2021. – ident: 2 – ident: 3 – ident: 4 – ident: 15 doi: 10.7883/yoken.JJID.2019.201 – ident: 10 doi: 10.1001/jama.300.5.520 – ident: 11 doi: 10.1371/journal.pone.0033328 – ident: 5 doi: 10.1097/EDE.0000000000000324 – ident: 12 – ident: 8 doi: 10.1186/1758-2652-12-19 – ident: 13 – ident: 14 doi: 10.1016/j.pmedr.2019.100994 – ident: 1 doi: 10.1093/oso/9780195076417.003.0008 – ident: 6 – ident: 9 – ident: 7 |
SSID | ssj0025510 |
Score | 2.2902732 |
Snippet | Accurate monitoring of epidemics is a key strategy for controlling human immunodeficiency virus type-1 (HIV-1) infection. To delineate the characteristics of... Accurate monitoring of epidemics is a key strategy for the control of human immunodeficiency virus type-1 (HIV-1) infection. To delineate the characteristic of... |
SourceID | proquest pubmed crossref jstage |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 395 |
SubjectTerms | Algorithms Avidity Biomarkers Ghana HIV HIV-1 Human immunodeficiency virus incidence Infections recent infection |
Title | Assessment of the Proportion of Recent HIV-1 Infections in Newly-Diagnosed Cases in Ghana |
URI | https://www.jstage.jst.go.jp/article/yoken/75/4/75_JJID.2021.573/_article/-char/en https://www.ncbi.nlm.nih.gov/pubmed/34980705 https://www.proquest.com/docview/2697154312 https://www.proquest.com/docview/2616600298 |
Volume | 75 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Japanese Journal of Infectious Diseases, 2022/07/31, Vol.75(4), pp.395-397 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR1db9Mw0CoDIV4Q3xQGChJvwyWxnTR-LAzoKg32sKGOl8hJHChlCWobofH3-GOcfYnTVgMxXqLKdk9O7nwfvi9Cnqd-IVmhQlqkuqBCZj6NU5ZRpoz8MQ5E20Xh8H00PhGTaTjt9X6tRS3Vq3SQ_bwwr-R_sApjgFeTJXsJzDqgMAC_Ab_wBAzD859wPHJlNVtX_5FperBotUDQCc3c-OAjDYATYNgVRo4Dc_t2Tvcx0M7c8oI0sxPvvihsqO1UVhCnpk3lZpEJhFUvWw-PU80P1WpZV3OF183VYtZFBNRLPaNH1bzGeH2TRJ4DfdRn6kw56TBKFaaprZU92PukUnraJa2ZkBJM0_lRL1SqS7X3Ia8bCdNcYTDW3o06rsuFoBHHPsQDjWNxLCjoPtE6q8YmKw1JijW-y7FTZyPCOYb8bksHsPZNlYrzaq7LwWRysD-AzQSDEHupbNbi3pKRLnIRbCYDJrFAEgMkMUASAHKFXGVgq9iM86mLMwKTDUtitO-Ipa8MkJcX7GRDPbr2FSyEz_rPxo9Vgo5vkZuN9eKNkBRvk54u75Drh018xl1y2lGkVxUeUKTXUaQZQYr0LEV6HUV6s9LbokjPUqSZsBR5j5y8fXP8ekyb5h00C1nIqZJRloPqk4P-oziXQuY515JzHnCuhNZBAcJWSRELPVSy8BlsoNChVjplgYr5fbJTVqV-SLzMz-VQW4exFMwv4syPclD9C1OrbhiHffKi_WbJd6zRkvwFT33yCr-rW9wc4GbxMEyEeWz8ya0xyZDAe_pkt8VJ0hy_ZcIiOQxMcQnWJ8_cNPBr44SDowqnEtYEkfWFx33yAHHp9sGFjEEEh48u90KPyY3uVO2SndWi1k9AVV6lTy0p_gYw9b91 |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Assessment+of+the+Proportion+of+Recent+HIV-1+Infections+in+Newly-Diagnosed+Cases+in+Ghana&rft.jtitle=Japanese+journal+of+infectious+diseases&rft.au=Matsuoka%2C+Saori&rft.au=Adusei-Poku%2C+Mildred+Asumamaa&rft.au=Abana%2C+Christopher+Zab-Yen&rft.au=Duker%2C+Ewurabena+Oduma&rft.date=2022-07-31&rft.issn=1344-6304&rft.eissn=1884-2836&rft.volume=75&rft.issue=4&rft.spage=395&rft.epage=397&rft_id=info:doi/10.7883%2Fyoken.JJID.2021.573&rft.externalDBID=n%2Fa&rft.externalDocID=10_7883_yoken_JJID_2021_573 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1344-6304&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1344-6304&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1344-6304&client=summon |